★ Tentative Program

BIT’s 5^th Annual Congress and Exposition of
Molecular Diagnostics (CEMD-2012)

Theme: Landscape of Technologies, Market and Superstars

Time: December 2-4, 2012

Venue: Guangzhou Baiyun International Convention Center

Program Layout

Track 1: Breaking Research on Molecular Diagnostics (MDx)

Track 2: Current and Emerging Technologies of MDx

Track 3: Applications of Molecular Diagnostics

Track 4: MDx in Pharmaceutical Industry and Healthcare

Track 5: Young Investigators’ Forum

Keynote Forum Time: 09:00-11:40, Dec. 2, 2012, (Saturday); Place: Foshan Hall, 2^nd Floor, Block 2, GZBICC
Moderator	*Dr. Peng Zhou,* CSO, Rheonix, Inc., USA
09:00-09:10	Moderator's Introtuction
09:10-09:40	*Title:* Taking Cancer Genomics to the Single Cell Level *Dr. James B. Hicks,* Research Professor and Director, Cold Spring Harbor Laboratory, USA
09:40-10:10	*Title:* Identification of Human Embryonic Stem Cells Using Signal Characteristic Analysis hE[SC]2AN *Dr. Hemchandra M. Shertukde,* President, Diagnostic Devices Inc., USA
10:10-10:40	*Title:* HAAH(Human Aspartyl (Asparaginyl) β-Hydroxylase), a Cancer Tumor Marker, as Companion Diagnostic Strategy *Dr. Mahmood Moshiri,* President/CEO, Panacea Global Inc., Canada
10:40-11:10	*Title:* Biomarkers in Drug Development, What is Now and What is Next *Dr. Karen Long, VP,* Abbott Molecular Inc., USA
11:10-11:40	Title: Rheonix CARD® – From Technology Innovation to FDA Registration Dr. Peng Zhou, CSO, Rheonix, Inc., USA

Track 1: Breaking Research on Molecular Diagnostics (MDx)
Topic 1: Major Challenges Facing Molecular Diagnostic Industries
Topic 2: Molecular Imaging, Chromosome Imaging and Molecular Medicine
Topic 3: Pharmacogenomics, Pharmacogenetics and Personalized Medicine
Topic 4: Metabolomics and Proteomic Technologies for Molecular Diagnostics

Track 1: Breaking Research on Molecular Diagnostics (MDx)
Time: 13:30-16:20, Dec. 2, 2012, (Sunday); Place: Room No. 3401, 4^th Floor, Block 3, GZBICC

Chair	*Dr. Richard M. Weinshilboum,* Professor, Mayo Clinic College of Medicine, USA
Co-chair	*Dr. Bhuwnesh Agrawal,*Chief Medical Officer and Head of Asia Pacific, Vela Diagnostics, Singapore

13:30-13:55	*Title:* Phamacogenomics: Beyond Biomarkers *Dr.* *Richard M. Weinshilboum*, Professor, Mayo Clinic College of Medicine, USA
13:55-14:20	*Title:* High Sensitivity Plasma Determination of Hepcidin, A Peptide Biomarker for Iron Metabolism, Using HPLC-Chip-ESI-MS *Dr.* *Jacques Crommen*, Professor, University of Liege, Belgium
14:20-14:45	*Title:* Proteomic Analysis of the Cervicovaginal Fluid Leads to Identification of Biomarkers for Cervix Cancer *Dr.Xaveer* Van Ostade**, Professor, University of Antwerp, Belgium
14:45-15:10	*Title:* Delivering Your Success: Providing Service Platform for Molecular Testing *Dr. Alexander Lezhava,* Director R&D, Dx assays, Singapore
15:10-15:30	Coffee Break
15:30-15:55	*Title:* Personalised Healthcare - Where are We Today and Where are We Heading? *Dr. Bhuwnesh Agrawal,* Chief Medical Officer and Head of Asia Pacific, Vela Diagnostics, Singapore
15:55-16:20	*Title:* RNA, DNA and Protein Biomarker Discovery from the Same Tissue Biopsy *Dr. Richard Fekete,* Sr. Manager, R&D, Life Technologies, USA

Track 2: Current and Emerging Technologies of MDx

Track 2: Current and Emerging Technologies of MDx
Time: 08:30-12:10, Dec. 3, 2012, (Monday); Place: Room No. 3401, 4^th Floor, Block 3, GZBICC

Chair	*Dr. Yi-Ming Liu, Professor,* Jackson State University, USA

08:30-08:55	*Title:* Pulsed Electromagnetic Fields Non-Invasively Stimulate Stem Cell Expansion for Clinical and Regenerative Science Applications *Dr. Alfredo Franco-Obregón,* Head, Swiss Federal Institute of Technology, Switzerland
08:55-09:20	*Title:* The Regulatory Role of THY1 On Other Putative Ovarian Tumor Suppressor Genes *Dr. Nancy Wang,* Professor, Department of Pathology Director, Cytogenetics Laboratory, University of Rochester Medical Center, USA
09:20-09:45	*Title:* The Role of Automated Quantitative FISH in the Diagnosis of Cervical Cancer *Dr. Vittorio Grazioli,* Head of Laboratories, CDI Centro Diagnostico Italiano S.p.A., Italy
09:45-10:10	*Title:* Design of Chemiluminescent Nanometer-sized Probes for Highly Sensitive Bioassays *Dr. Yi-Ming Liu,* Professor, Jackson State University, USA
10:10-10:30	Coffee Break
10:30-10:55	*Title: DNA Sensor for Medical Diagnostic: Use of Synthetic Biology* *Dr. Raul Cuero,* Scientist/Research Director, International Parks of creativity, Colombia
10:55-11:20	*Title:* Microchannel Flow Control, Electric Measurement, and Dielectrophoretic Manipulation to Analyze Single Cell Characteristics *Dr. Kazuyoshi Nakabe,*Professor, Kyoto University, Japan
11:20-11:45	*Title:* On-chip SortTM: Cell Analyzing and Sorting System Using Disposable Microfluidic Chip and Air Pressure Control System *Dr. Kazuo Takeda,* Director, On-chip biotechnologies, Co., Ltd., Japan
11:45-12:10	*Title:* Circulating Endothelial Cells in Chronic Renal Failure Rats *Dr. Hazilawati Hamzah,*Senior Lecturer and Coordinator, Universiti Putra Malaysia, Malaysia

Track 3: Applications of Molecular Diagnostics
Track 3-1: Applications of Molecular Diagnostics
Topic 1: Infectious Disease Diagnostics

Topic 2: Inherited Disorders

Track 3-1: Applications of Molecular Diagnostics
Time: 13:30-15:30, Dec. 3, 2012, (Monday); Place: Room No. 3401, 4^th Floor, Block 3, GZBICC

Chair	*Dr. Jane SC Tsai,* Deputy General Director, ITRI, Taiwan

13:30-13:50	*Title: Clinical Applications of Genotyping* *Dr. Jane SC Tsai,* Deputy General Director, ITRI, Taiwan
13:50-14:10	*Title:* xTAG – A Multiple Molecular Diagnosis Platform *Mr. James Xing,* Field Marketing Scientist, Luminex Corporation, China
14:10-14:30	*Title: Strongyloides Venezuelensis Protein Used in the Epidemiological and Clinical Diagnosis of Human Strongyloidiasis* *Dr. Eleuza Rodrigues Machado*, Professor & Researcher, Brasilia University, Brazil
14:30-14:50	*Title: Biomarker: Its Potential for the Detection and Prediction of Common Genetic Disorders* *Dr. Subrata Kumar Dey,* Director, West Bengal University of Technology, India
14:50-15:10	*Title:* Human Aspartyl (Asparaginyl) β-Hydroxylase (HAAH) Levels as an Indicator for Patients at Risk for Prostate Cancer *Dr. Mahmood Moshiri,* President/CEO, Panacea Global Inc., Canada
15:10-15:30	Coffee Break

Track 3-2: MDx for Cancer
Time: 15:30-16:20, Dec. 3, 2012, (Sunday); Place: Room No. 3401, 4^th Floor, Block 3, GZBICC

Chair	*Dr. Mahmood Moshiri,* President/CEO, Panacea Global Inc., Canada
Co-chair	*Dr. Zhiyuan Hu*, Director of Rapid Adoption Molecular Laboratory, University of North Carolina at Chapel Hill at Chapel Hill, USA

15:30-15:55	*Title: Breast Cancer Biomarker Discovery by Whole Transcriptome RNA-Seq in Formalin-Fixed Paraffin-Embedded Tumor Tissue* *Dr. Kunbin Qu,* Director of Bioinformatics, Genomic Health, Inc., USA
15:55-16:20	*Title: Prognostic Prediction of a 13-gene VEGF Signature in Breast Cancer* *Dr.* *Zhiyuan Hu*, Director of Rapid Adoption Molecular Laboratory, University of North Carolina at Chapel Hill, USA

Track 4: MDx in Pharmaceutical Industry and Healthcare

Topic 1: MDx in Drug Discovery and Development
Topic 2: MDx in Quality Control of Protein Therapeutics and Vaccines
Topic 3: MDx in Gene Therapy
Topic 4: MDx in Pharmaceutical Processing and Distribution
Topic 5: Molecular Diagnostics for Organ Transplantation
Topic 6: MDx in Molecular Epidemiology and Genetic Diseases
Topic 7: Role of Molecular Diagnostics in Future Healthcare

Topic 8: Therapy based on Molecular Diagnosis from Companion Test to POC Diagnostics

Track 4: MDx in Pharmaceutical Industry and Healthcare
Time: 08:30-10:30, Dec. 4, 2012, (Tuesday); Place: Room No. 3401, 4^th Floor, Block 3, GZBICC

Chair	*Dr. Pamela L. Swatkowski*, Director, Abbott Molecular, Inc., USA

08:30-08:55	Title: Best Practices in Companion Diagnostics *Dr. Pamela L. Swatkowski*, Director, Abbott Molecular, Inc., USA
08:55-09:20	*Title: Rapid Raman Spectroscopy for Melanoma Screening* *Dr.* *Thomas A Braun*, CEO, Verisante Technology, Inc., Canada
09:20-09:45	*Title: Evolution of the i-STAT Analyzer for DNA* *Dr. Bruce Collier,* Principal Research Scientist, Abbott Point of Care,Canada
09:45-10:10	*Title:* The Economic Impact of Biomarker-based Testing within the Companion Diagnostics (Cdx)-Stratified Medicine Ecosystem *Dr. Alan K. Hauser,* Executive Director, Bio-Com International, USA
10:10-10:30	Coffee Break

Track 5: Young Investigators’ Forum

Track 5: Young Investigators’ Forum
Time: 10:30-11:45, Dec. 4, 2012, (Tuesday); Place: Room No. 3401, 4^th Floor, Block 3, GZBICC

Chair	*Dr. Kestutis G. Bendinskas,* Associate Professor, State University of New York at Oswego, USA

10:30-10:55	*Title: Glutamate Dehydrogenase Activity in Cerebrospinal Fluid* *Dr. Matej Kravos,* Assistant professor, University of Maribor, Slovenia
10:55-11:20	*Title: Lead, Mercury, Cortisol, and Inflammatory Proteins in Adolescents* *Dr.* *Kestutis G. Bendinskas*, Associate Professor, State University of New York at Oswego, USA
11:20-11:45	*Title: Plasma Biomarkers of Abdominal Aortic Aneurysms* *Dr.* *Saima Ehsan,* Fellow, University of Leicester, UK

Download Conference
Brochure Click Here

Hosting Organization

Information Research Center of International Talents, SAFEA

China Medicinal Biotech Association

Operating Organization

BIT Congress Inc.

Foreign Experts Databank
of SAFEA-Dalian Biotechnological and Medical Experts Subdivision

★ Tentative Program

Hosting Organization

Operating Organization

Media Partners